Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer

NCT00324740 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

14

Enrollment

NIH

Sponsor class

Conditions

Recurrent Renal Cell Cancer
Stage III Renal Cell Cancer
Stage IV Renal Cell Cancer

Interventions

DRUG: vorinostat
DRUG: isotretinoin

Sponsor

National Cancer Institute (NCI)